For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Synergy Pharmaceuticals, Inc.

USPTO Granted Patents = 34

CIPO Patents = 7

EPO Patents = 13

Trademarks = 2

Forward Citations = 478

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Kunwar Shailubhai (34 out of 50 patents)

Gary S Jacob (14 out of 33 patents)

Stephen Comiskey (8 out of 23 patents)

4. Rong Feng (7 out of 13 patents)

5. John Foss (5 out of 5 patents)

6. Gregory Nikiforovich (3 out of 4 patents)

7. Juncai Bai (2 out of 8 patents)

8. Ruoping Zhang (2 out of 8 patents)

9. Jun Jia (2 out of 7 patents)

10. Qiao Zhao (2 out of 9 patents)

11. Junfeng Zhou (2 out of 8 patents)

12. Guoqing Zhang (1 out of 9 patents)

13. Dennis Riff (1 out of 3 patents)

14. Patrick H Griffin (1 out of 4 patents)

15. Guoquing Zhang (1 out of 2 patents)

34 patents: Sort by Forward Citations

1. 10238712 - Compositions useful for the treatment of gastrointestinal disorders (2019-03-26),

2. 10232011 - Formulations of guanylate cyclase C agonists and methods of use (2019-03-19),

3. 10118946 - Agonists of guanylate cyclase and their uses (2018-11-06),

4. 10034836 - Formulations of guanylate cyclase C agonists and methods of use (2018-07-31),

5. 10011637 - Ultra-pure agonists of guanylate cyclase C, method of making and using same (2018-07-03),

6. 9925231 - Formulations of guanylate cyclase C agonists and methods of use (2018-03-27),

7. 9920095 - Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders (2018-03-20),

8. 9919024 - Formulations of guanylate cyclase C agonists and methods of use (2018-03-20),

9. 9914752 - Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders (2018-03-13),

10. 9814752 - Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases (2017-11-14),

11. 9708367 - Agonists of guanylate cyclase and their uses (2017-07-18),

12. 9616097 - Formulations of guanylate cyclase C agonists and methods of use (2017-04-11),

13. 9610321 - Formulations of guanylate cyclase C agonists and methods of use (2017-04-04),

14. 9580471 - Process of preparing guanylate cyclase C agonists (2017-02-28),

15. 9545446 - Agonists of guanylate cyclase and their uses (2017-01-17),

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for gastrointestinal diseases. Their mission is to improve the lives of patients by bringing innovative treatments to market. With a pipeline of potential drug candidates and a strong commitment to research and development, Synergy Pharmaceuticals strives to address the unmet needs of patients suffering from varying gastrointestinal disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

34 Patents

#225 in New York, NY

#545 in New York

#9,663 in US

#19,027 in the World

New York, NY, United States of America

Synergy Pharmaceuticals, Inc.

Forward Citations = 478

15 inventors:

Kunwar Shailubhai (34 out of 50 patents)

Gary S Jacob (14 out of 33 patents)

Stephen Comiskey (8 out of 23 patents)

4. Rong Feng (7 out of 13 patents)

5. John Foss (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…